Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
50.77
Nov 11 • 3:59 PM ET Dollar change-0.44 Percentage change(-0.86%)
Aftermarket Close
50.77
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
1.51B
Enterprise Value
2.28B
Income
73.43M
Sales
1.37B
Book/sh
35.49
Cash/sh
1.61
Employees
3900
IPO
Jul 23, 1987
P/E
21.03
Forward P/E
10.69
PEG
2.37
P/S
1.10
P/B
1.43
P/C
31.54
P/FCF
11.40
EV/EBITDA
30.01
EV/Sales
1.66
Quick Ratio
0.70
Current Ratio
1.49
Debt/Eq
0.77
LT Debt/Eq
0.60
Option/Short
Yes / Yes
EPS (ttm)
2.41
EPS next Y
4.75
EPS next Q
1.26
EPS this Y
-0.37%
EPS next Y
3.84%
EPS next 5Y
4.51%
EPS past 3/5Y
- 36.14%
Sales past 3/5Y
10.08% 9.82%
EPS Y/Y TTM
16.93%
Sales Y/Y TTM
1.93%
EPS Q/Q
613.46%
Sales Q/Q
-0.88%
Insider Own
0.39%
Insider Trans
0.00%
Inst Own
112.01%
Inst Trans
0.50%
ROA
3.17%
ROE
7.10%
ROIC
4.33%
Gross Margin
44.85%
Oper. Margin
1.59%
Profit Margin
5.36%
SMA20
4.72%
SMA50
7.74%
SMA200
21.52%
Trades
Shs Outstand
29.87M
Shs Float
29.69M
52W High
54.80 -7.35%
52W Low
31.44 61.48%
Volatility
3.28% 4.58%
ATR (14)
2.14
RSI (14)
57.59
Beta
0.87
Rel Volume
0.56
Avg Volume
365.20K
Volume
204,887
Perf Week
-5.39%
Perf Month
11.46%
Perf Quarter
1.91%
Perf Half Y
42.81%
Perf YTD
25.05%
Perf Year
13.55%
Perf 3Y
-48.47%
Perf 5Y
-66.40%
Perf 10Y
13.83%
Prev Close
51.21
Price
50.77
Change %
-0.86%
Consensus
Hold
Avg. Price Target
$46.83
Implied Upside
-7.8%
Analysts13incl. previous ratings
Rating Distribution5 Buy · 7 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Jul 09, 2026Initiated
BMO logoBBMO Capital Markets
Market Perform$36-29.1%
Jun 29, 2026Downgrade
BAC logoBBofA Securities
Neutral → Underperform$40-21.2%
Mar 17, 2026Downgrade
PPiper Sandler
Overweight → Neutral$39-23.2%
Jun 12, 2025Downgrade
NNeedham
Buy → Hold
Apr 28, 2025Downgrade
SF logoSStifel
Buy → Hold$55+8.3%
Feb 06, 2025Downgrade
JPM logoJJP Morgan
Overweight → Neutral$85 → $70+37.9%
Feb 01, 2024Reiterated
NNeedham
Buy$119 → $129+154.1%
May 22, 2023Initiated
CCL King
Buy$140+175.8%
Mar 27, 2023Upgrade
KEY logoKKeyBanc Capital Markets
Sector Weight → Overweight$124+144.2%
Mar 21, 2023Initiated
WFC logoWWells Fargo
Equal Weight$96+89.1%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foust Hollie KGeneral Counsel & Corp SecNov 04 '26Option Exercise0.004,00006,886Nov 06 03:02 PM
Kelderman KimDirectorSep 08 '26Option Exercise0.005000500Sep 10 03:13 PM
Bronson David M.DirectorJun 02 '26Option Exercise0.00668017,909Jun 03 04:22 PM
Council LaVerne HDirectorJun 02 '26Option Exercise0.0066804,716Jun 03 04:18 PM
Farkas CharlesDirectorJun 02 '26Option Exercise0.00668015,527Jun 03 04:12 PM
Kaye MarkDirectorJun 02 '26Option Exercise0.006680820Jun 03 04:10 PM
Schwarzentraub Barbara JDirectorJun 02 '26Option Exercise0.0066805,012Jun 03 04:07 PM
Lalomia BrentExecutive VP RA, QAMar 06 '26Option Exercise0.00750941Mar 10 02:40 PM
Kaye MarkDirectorFeb 24 '26Option Exercise0.001520152Feb 26 09:23 AM
Glaze RichardChief Information OfficerNov 21 '25Sale41.2125710,5910Nov 24 01:18 PM
Glaze RichardChief Information OfficerNov 20 '25Option Exercise0.003750375Nov 21 03:39 PM
Glaze RichardOfficerNov 21 '25Proposed Sale41.2125710,591Nov 21 09:40 AM
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
PresidentMr. Patrick J. Beyer
Executive VPMs. Hollie K. Foust
Executive Vice President of Strategy & Corporate DevelopmentMr. Peter K. Shagory